Inozyme Pharma, Inc. CEO and Chairman Doug Treco, Ph.D., will be participating in a fireside chat at the Bank of America Securities 2024 Health Care Conference on May 15th, 2024. The chat will take place from 6:40-7:10pm ET / 3:40-4:10pm PT and can be accessed through the Investor Relations section of Inozyme’s website under events. A replay of the event will also be available for a limited time.
Inozyme Pharma is a clinical-stage rare disease biopharmaceutical company that focuses on developing novel therapeutics for diseases affecting vasculature, soft tissue, and skeleton. The company is currently working on an enzyme replacement therapy, INZ-701, which aims to address pathologic mineralization and intimal proliferation that can lead to severe health issues. INZ-701 is in clinical development for the treatment of ENPP1 Deficiency, ABCC6 Deficiency, and calciphylaxis.
For more information about Inozyme Pharma or its products, visit their website at
Gathered on the boardwalk at Jones Beach, thousands of people participated in a fundraiser for…
In recent news, the New York Mets have decided to remove Edwin Díaz from his…
Mark Wells, a beloved forward on the 1980 U.S. Olympic champion men's hockey team, has…
In a groundbreaking study, retired naval officer Joseph Dituri was chosen to spend over three…
The Museum of Science and Industry in Chicago recently underwent a major transformation. In honor…
Wyatt Hendrickson, a two-time All-American wrestler from the Air Force Academy, has decided to transfer…